Incidence of electrocardiographic abnormalities during treatment with human leukocyte interferon-alfa in patients with chronic hepatitis C but without preexisting cardiovascular disease
- 31 October 1998
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 59 (10) , 692-696
- https://doi.org/10.1016/s0011-393x(98)85027-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Adverse Effects of Interferon on the Cardiovascular System in Patients with Chronic Hepatitis C.Japanese Heart Journal, 1996
- Assessment of interferon cardiotoxicity with quantitative radionuclide angiocardiographyEuropean Journal of Clinical Investigation, 1995
- Clinical Toxicity of the InterferonsDrug Safety, 1994
- Recombinant interleukin-2 and recombinant interferon α immunotherapy cardiovascular toxicityAmerican Heart Journal, 1992
- Cardiotoxicity of Interferon*Chest, 1991
- Treatment of Chronic Type C Hepatitis with Alpha InterferonSeminars in Liver Disease, 1989
- Recombinant alpha2 interferon-related cardiomyopathyThe American Journal of Medicine, 1988